Bamco Inc Denali Therapeutics Inc. Transaction History

Bamco Inc

$36.8 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$21.91 - $32.67 $4.68 Million - $6.98 Million	-213,756 Reduced 80.89%	50,500 $1.16 Million
Q4 2022 Feb 14, 2023	SELL	$26.28 - $33.92 $278,725 - $359,755	-10,606 Reduced 3.86%	264,256 $7.35 Million
Q3 2022 Nov 14, 2022	SELL	$25.97 - $38.53 $21,892 - $32,480	-843 Reduced 0.31%	274,862 $8.44 Million
Q2 2022 Aug 15, 2022	SELL	$20.88 - $35.19 $7.93 Million - $13.4 Million	-379,643 Reduced 57.93%	275,705 $8.11 Million
Q1 2022 May 13, 2022	SELL	$29.0 - $47.27 $9.89 Million - $16.1 Million	-340,956 Reduced 34.22%	655,348 $21.1 Million
Q4 2021 Feb 14, 2022	SELL	$42.59 - $55.02 $5.61 Million - $7.24 Million	-131,615 Reduced 11.67%	996,304 $44.4 Million
Q3 2021 Nov 12, 2021	SELL	$48.48 - $78.23 $6.17 Million - $9.96 Million	-127,305 Reduced 10.14%	1,127,919 $56.9 Million
Q2 2021 Aug 13, 2021	BUY	$50.3 - $78.44 $2.28 Million - $3.56 Million	45,400 Added 3.75%	1,255,224 $98.5 Million
Q1 2021 May 19, 2021	BUY	$53.8 - $81.53 $7.88 Million - $11.9 Million	146,418 Added 13.77%	1,209,824 $69.1 Million
Q4 2020 Feb 12, 2021	BUY	$36.89 - $93.56 $3.88 Million - $9.84 Million	105,200 Added 10.98%	1,063,406 $89.1 Million
Q3 2020 Nov 13, 2020	BUY	$23.13 - $38.84 $121,409 - $203,871	5,249 Added 0.55%	958,206 $34.3 Million
Q4 2019 Feb 18, 2020	SELL	$14.4 - $19.99 $456,552 - $633,782	-31,705 Reduced 3.22%	952,957 $16.6 Million
Q1 2019 May 15, 2019	BUY	$17.99 - $24.65 $13,672 - $18,734	760 Added 0.08%	984,662 $22.9 Million
Q4 2018 Feb 14, 2019	BUY	$13.88 - $21.75 $395,580 - $619,875	28,500 Added 2.98%	983,902 $20.3 Million
Q3 2018 Nov 14, 2018	BUY	$12.46 - $21.74 $123,852 - $216,095	9,940 Added 1.05%	955,402 $20.8 Million
Q2 2018 Aug 14, 2018	BUY	$15.25 - $21.02 $487,039 - $671,315	31,937 Added 3.5%	945,462 $14.4 Million
Q1 2018 May 09, 2018	BUY	$15.36 - $24.8 $6.51 Million - $10.5 Million	423,525 Added 86.43%	913,525 $18 Million
Q4 2017 Feb 14, 2018	BUY	$15.04 - $21.45 $7.37 Million - $10.5 Million	490,000	490,000 $7.66 Million

Others Institutions Holding DNLI

# of Institutions

227

Shares Held

119M

Call Options Held

60.6K

Put Options Held

48.4K

Baillie Gifford & CO

13.3M
Shares

$287 Million
0.3% of portfolio
Black Rock Inc. New York, NY

13.2M
Shares

$283 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

11.2M
Shares

$240 Million
0.01% of portfolio
Wellington Management Group LLP Boston, MA

10.7M
Shares

$231 Million
0.06% of portfolio
Capital Research Global Investors Los Angeles, CA

7.91M
Shares

$170 Million
0.05% of portfolio

View Full List

About Denali Therapeutics Inc.

Ticker DNLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 134,174,000
Market Cap $2.88B
Description
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...

More about DNLI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bamco Inc , based on Form 13F filings with the SEC.

News

Stay updated on Bamco Inc with notifications on news.

Account